Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Lease liabilities, net | (758) | (653) |
| Net cash used in operating activities | (33,304) | (26,328) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (123) | (148) |
| Purchases of intangible assets | — | (20) |
| Net cash used in investing activities | (123) | (168) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock under at-the-market offering program, net of issuance costs | 46,392 | — |
Document
FAQ
- What is Pulse Biosciences, Inc.'s capex?
- Pulse Biosciences, Inc. (PLSE) reported capex of $90K in Q2 2026.
- How has Pulse Biosciences, Inc.'s capex changed year-over-year?
- Pulse Biosciences, Inc.'s capex decreased by 12.6% year-over-year, from $103K to $90K.
- What is the long-term trend for Pulse Biosciences, Inc.'s capex?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s capex has grown at a -7.9% compound annual growth rate (CAGR), from $437K to $315K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Pulse Biosciences, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude